Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acquired immunodeficiency syndrome
acquired immunodeficiency syndrome dementia complex
acquired immunodeficiency syndrome, older adults
activated protein C resistance
aducanumab
advance directives
advances in neurology
adverse drug reaction
aerobic exercise
age associated memory impairment
aggression
agitation
algorithm
aluminum
Alzheimer's disease
Alzheimer's disease, conjugal
Alzheimer's disease, diagnosis of
Alzheimer's disease, driving with
Alzheimer's disease, early onset
Alzheimer's disease, early symptoms
Alzheimer's disease, familial
Alzheimer's disease, familial, late onset
Alzheimer's disease, incidence
Alzheimer's disease, misdiagnosis
Alzheimer's disease, pathogenesis
Alzheimer's disease, patient awareness of
Alzheimer's disease, preclinical
Alzheimer's disease, rapidly progressive
Alzheimer's disease, rate of clinical decline
Alzheimer's disease, risk factors in
Alzheimer's disease, treating associated medical problems in
Alzheimer's disease, treatment of
amnesia
amyloid
amyloid beta protein
amyloid beta protein antibodies
amyloid deposition
amyloid imaging
amyloid plaques
amyloidosis
amyloid-related imaging abnormalities
amyotrophic lateral sclerosis
anatomy of
angiotensin II receptor blocker
anti-amyloid therapy
anticoagulant, treatment
anticonvulsants
antihypertensive
antiphospholipid antibodies
antithrombin III deficiency
anxiety
apolipoprotein E
apoliprotein E, plasma level
APP
APP gene
asymptomatic
atrial fibrillation
atypical
automobile accidents
autonomic dysfunction
behavioral disorder
benzodiazepine
biologic markers
blacks
blood pressure
blood transfusion
bone density
carcinoma
caregiver
CAT scan
CAT scan, abnormal
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, venography
cerebral edema
cerebral edema, vasogenic
cerebral infarction
cerebral venous infarction
cerebral venous thrombosis
cerebral venous thrombosis, deep
cerebral venous thrombosis, etiology
cerebral venous thrombosis, recurrent
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, biochemical markers of CNS disease
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, familial occurrence
cerebrovascular accident, infancy and childhood
cerebrovascular accident, prevention of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, women
cerebrovascular accident, work up for
cerebrovascular accident, young adult
cerebrovascular disease
cerebrovascular disease, risk factors in
children
chromosomal abnormality
chromosome 12
cigarette smoking
clinical trials
cognition
comorbidities
complications
confusion
contraindications
controversies in neurology
cost
coumarin
craniectomy, decompressive
D-dimer
degenerative diseases of CNS
dementia
dementia, cerebrovascular disease causing
dementia, clinical diagnosis
dementia, diagnostic evaluation of
dementia, differential diagnosis of
dementia, driving with
dementia, early detection
dementia, familial
dementia, incidence
dementia, prevalence of
dementia, prevention of
dementia, rapidly progressive
dementia, screening for
dementia, treatment of
depression
diabetes mellitus
diagnostic criteria
disease modifying agents
dizziness
donanemab
donepezil
driving
drug abuse
dural sinus thrombosis
educational status
efficacy
electromagnetic fields
endovascular therapy
epidemiology of neurology
ethics in neurology
evidence-based research
exercise
Factor V Leiden
familial
fibrinolytic agents
fibrinolytic agents, intra-venous local infusion
fibrinolytic agents, utilization
fracture, long bone
gadolinium
gantenerumab
gender
gene
genetic counselling
genetic linkage
genetic neurologic disorders
genetic screening
genetic testing
glaucoma
haloperidol
head injury
headache
hemiparesis
hemosiderosis of CNS, superficial
heralding manifestation
herpes simplex virus
hip fracture
hippocampal atrophy
hippocampus
Hispanics
homocysteine, serum
homosexual
hormone replacement
hormone therapy
human immunodeficiency virus type 1
hydrocephalus
hypercholesterolemia
hyperhomocysteinemia
hyperinsulinism
hypertension
hypoxia
iatrogenic neurologic disorders
incidence
intellectual deficit
intellectual deterioration
intracerebral hemorrhage
intracranial pressure, increased
inverse association
Jakob-Creutzfeldt disease
lecanemab
leisure activity
level of consciousness, decreased
lifestyle
limbic system
limbic-predominant age-related TDP-43 encephalopathy
lipid lowering agent
managed care
marital status
medical-legal aspects of neurology
memory
memory, defect of recent
memory, evaluation of
memory, impairment of
memory, impairment of, isolated
memory, impairment of, subjective
meningitis
menopause
mental activity
mental status, abnormal
mesial temporal lobe
microhemorrhage, intracerebral
middle cerebral artery territory infarction
middle cerebral artery, occlusion of
mild cognitive impairment
mild cognitive impairment converting to Alzheimer's disease
mimics
Mini Mental Status Examination
misdiagnosis
molecular genetics
mongolism
monoclonal antibodies
mortality
motor neuron disease
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, functional
MRI, venography
multiple sclerosis
myoclonus
negative
nerve growth factor
neurofibrillary degeneration
neuroleptic
neuroleptic, atypical
neurologic complications of, systemic disease
neurologic consultation
neurologic disease, diagnoses of
neurologic evaluation
neurologic examination, focal
neurologic signs
neurologic symptoms
neuropathology
neuropathy
neuroprotective agents
nicotine
nonsteroidal anti-inflammatory drug
normal
occupational neurologic disorders
old age, driving and
old age, neurology of
oral contraceptives
oral contraceptives, cerbrovascular disease and
oral contraceptives, neurologic complications with
osteoporosis
Parkinson disease
Parkinson disease, etiology of
patient information and support
pitfalls
Pittsburgh Compound B
placebo
polysomnogram
practice guidelines
preclinical
pregnancy, neurologic complications in
premarin
presenilin-1 gene
presenilin-2 gene
prethrombotic state
prevention of neurologic disorders
progesterone
prognosis
protein C deficiency
protein S deficiency
proteinopathy
psychological testing
psychotic behavior
remternetug
research
review article
rhinorrhea, CSF
risk factors
risk factors, modification
risk-benefit assessment
risperidone
rosacea
safety
screening
seizure
seizure, elderly
seizure, focal
seizure, risk factors for
selective serotonin reuptake inhibitors
senile plaques
shared decision making
sildenafil
skin, lesions in neurologic disorders
sleep
sleep pathology and physiology
smell
Smell Identification Test
sodium-glucoe cotransporter-2 inhibitors
straight sinus
stress, emotional
superior sagittal sinus thrombosis
tau protein
TDP-43 proteinopathy
temporal lobe, atrophy
tissue plasminogen activator, intravenous
TRAILBLAZER-ALZ trial
treatment of neurologic disorder
TREM2 variants
water, drinking
weight loss
white matter disease
whites
workup
Showing articles 800 to 850 of 7284 << Previous Next >>

Subtherapeutic International Normalized Ratio in Warfarin-Treated Patients Increases the Risk for Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis
Stroke 42:2333-2335, Seet, R.C.S.,et al, 2011

Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
NEJM 364:2187-98, 2256, Smith, C.R.,et al, 2011

Guideline on the Management of Patients with Extracranial Carotid and Vertebral Artery Disease
Stroke 42:e420-e463, Brott, T.G.,et al, 2011

Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy
NEJM 365:285-287, Egan, A.,et al, 2011

Ischemic Stroke and Transient Ischemic Attack After Head and Neck Radiotherapy
Stroke 42:2410-2418, Plummer, C.,et al, 2011

Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurence
Stroke 42:2509-2514, Broderick, J.,et al, 2011

Association Between Stroke and Patients with Pelvic Inflammatory Disease A Nationwide Population-Based Study in Taiwan
Stroke 42:2074-2076, Chen, P.C.,et al, 2011

Etiologic investigation of ischemic stroke in young adults
Neurol 76:1983-1988, Larrue, V.,et al, 2011

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 69:1060-1062, Phan-Ba, R.,et al, 2011

Trigger Factors and Their Attributable Risk for Rupture of Intracranial Aneurysms A Case-Crossover Study
Stroke 42:1878-1882, Vlak, M.H.M.,et al, 2011

Microbleeds are Associated with Subsequent Hemorrhagic and Ischemic Stroke in Healthy Elderly Individuals
Stroke 42:1867-1871, Bokura, H.,et al, 2011

Clinical Relevance of Improved Microbleed Detection by Susceptibility-Weighted Magnetic Resonance Imaging
Stroke 42:1894-1900, Goos, J.D.C.,et al, 2011

Seizure risk from cavernous or arteriovenous malformations
Neurol 76:1548-1554, Josephson, C.B.,et al, 2011

Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data
Pharmacol Ther 129:185-194, Terry, K.W.,et al, 2011

Post-acute care and secondary prevention after ischaemic stroke
BMJ 342:d2083, McArthur, K.S.,et al, 2011

Prevalence of MRI-defined recent silent ischemia and associated bleeding risk with thrombolysis
Neurol 76:1288-1295, Tisserand, M.,et al, 2011

Bacterial Meningitis in the United States, 1998-2007
NEJM 364:2016-25, Thigpen, M.C.,et al, 2011

Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis
Neurol 76:1858-1865, OConnor, P.W.,et al, 2011

Clinical and MRI characteristics of acute migrainous infarction
Neurol 76:1911-1917, Wolf, M.E.,et al, 2011

HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
NEJM 364:1134-1143, McCormack,M.,et al, 2011

HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
NEJM 364:1126-1133, Chen,P.,et al, 2011

Genes Associated With Adult Cerebral Venous Thrombosis
Stroke 42:913-918, Marjot,T.,et al, 2011

Incidence and Predictors of Myocardial Infarction After Transient Ischemic Attack: A Population-Based Study
Stroke 42:935-940, Burns,J.D.,et al, 2011

Temporal Onset, Risk Factors, and Outcomes Associated With Stroke After Coronary Artery Bypass Grafting
JAMA 305:381-390, Tarakji,K.G.,et al, 2011

Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:512-584, Goldstein,L.B.,et al, 2011

Increased Risk of Stroke in the Year After a Hip Fracture: A Population-Based Follow-Up Study
Stroke 42:336-341, Kang,J.-H.,et al, 2011

Newer-Generation Antiepileptic Drugs and the Risk of Major Birth Defects
JAMA 305:1996-2002, Molgaard, D. & Hviid, A., 2011

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
Neurol 76:1697-1704, Vermersch,P.,et al, 2011

The use of rituximab in myasthenia gravis and Lambert--Eaton myasthenic syndrome
JNNP 82:671-673, Maddison, P.,et al, 2011

Statin Use Following Intracerebral Hemorrhage
Arch Neurol 68:573-579, Westover, M.B.,et al, 2011

Nonconvulsive Seizures are Common in Critically Ill Children
Neurol 76:1071-1074, Abend,N.S.,et al, 2011

A Randomized Trial of Prenatal Versus Postnatal Repair of Myelomeningocele
NEJM 364:993-1004, 1076, Adzick,N.S.,et al, 2011

Delirium in the Acute Phase After Stroke
Neurol 76:993-999, Oldenbeuvig,A.W., et al, 2011

Apixaban in Patients With Atrial Fibrillation
NEJM 364:806-817, Connolly,S.J.,et al, 2011

Use of Ibuprofen and Risk of Parkinson Disease
Neurol 76:863-869, Gao,X.,et al, 2011

Incidence of Cerebral Microbleeds in the General Population: The Rotterdam Scan Study
Stroke 42:656-661, Poels,M.M.F.,et al, 2011

Cerebral Microbleeds Are Predictive of Mortality in the Elderly
Stroke 42:638-644, Altmann-Schneider,I.,et al, 2011

Increased Risk of Stroke After Discontinuation of Acetlysalicylic Acid: A UK Primary Care Study
Neurol 76:740-746, Rodr�guez,L.A.G.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy
Arch Neurol 68:186-191, Miravalle,A.,et al, 2011

Risk of Stroke in Patients Hospitalized for Isolated Vertigo: A Four-Year Follow-Up Study
Stroke 42:48-52, Lee,C.-C.,et al, 2011

Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:227-276, Furie,K.L.,et al, 2011

New Alternative to Warfarin May Help Reduce Stroke Risk in Patients With AF
JAMA 305:25-26, Mitka,M., 2011

HIV Disease in the Caribbean
Top Antivir Med 19:e1-e5, Pape, J.W.,et al, 2011

Tourettes Syndrome
NEJM 363:2332-2338, Kurlan,R., 2010

Association Between Familial Atrial Fibrillation and Risk of New-Onset Atrial Fibrillation
JAMA 304:2263-2269, Lubitz,S.A.,et al, 2010

Intrauterine Exposure to Carbamazepine and Specific Congenital Malformations: Systematic Review and Case-Control Study
BMJ 341:c6581, 1229, Jentik,J.,et al, 2010

Hepatitis C Virus Infection and Increased Risk of Cerebrovascular Disease
Stroke 41:2894-2900, Lee,M.-H.,et al, 2010

10-Year Stroke Prevention After Successful Carotid Endarterectomy for Asymptomatic Stenosis (ACST-1): A Multicentre Randomised Trial
Lancet 376:1074-1084, Halliday,A.,et al, 2010

Short-Term Outcome After Stenting Versus Endarterectomy for Symptomatic Carotid Stenosis: A Preplanned Meta-Analysis of Individual Patient Data
Lancet 376:1062-1073, 1028, Amarenco,P.,et al, 2010

Quality of Anticoagulation Control in Atrial Fibrillation
Lancet 376:935-937, Lane,D.A. &Lip,G.Y.H., 2010



Showing articles 800 to 850 of 7284 << Previous Next >>